714954-37-7 (（+）-依西司他丁A,(+)-irciniastatin A)

(+)-irciniastatin A;irciniastatin A;psymberin;(+)-Psymberin;(+)-Iriciniastatin A;(2S,3S)-N-[(S)-[(2S,4R,6R)-6-[(2S,3R)-3-[(3R)-6,8-dihydroxy-5-methyl-1-oxo-3,4-dihydroisochromen-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxan-2-yl]-methoxymethyl]-2-hydroxy-3-methoxy-5-methylhex-5-enamide;SAK6W44ZUP;SCHEMBL13496618;(2S,3S)-N-((S)-((2S,4R,6R)-6-((2S,3R)-3-((3R)-3,4-Dihydro-6,8-dihydroxy-5-methyl-1-oxo-1H-2-benzopyran-3-yl)-2-hydroxybutyl)tetrahydro-4-hydroxy-5,5-dimethyl-2H-pyran-2-yl)methoxymethyl)-2-hydroxy-3-methoxy-5-methyl-5-hexenamide;CHEBI:182709;5-Hexenamide, N-((S)-((2S,4R,6R)-6-((2S,3R)-3-((3R)-3,4-dihydro-6,8-dihydroxy-5-methyl-1-oxo-1H-2-benzopyran-3-yl)-2-hydroxybutyl)tetrahydro-4-hydroxy-5,5-dimethyl-2H-pyran-2-yl)methoxymethyl)-2-hydroxy-3-methoxy-5-methyl-, (2S,3S)-;(2S,3S)-N-[(S)-[(2S,4R,6R)-6-[(2S,3R)-3-[(3R)-3,4-Dihydro-6,8-dihydroxy-5-methyl-1-oxo-1H-2-benzopyran-3-yl]-2-hydroxybutyl]tetrahydro-4-hydroxy-5,5-dimethyl-2H-pyran-2-yl]methoxymethyl]-2-hydroxy-3-methoxy-5-methyl-5-hexenamide;DTXSID301098104;714954-37-7;Psymberin, (+)-;

BNNIEBYABSNREN-CYRUSRGFSA-N

1S/C31H47NO11/c1-14(2)9-22(40-7)27(37)28(38)32-29(41-8)23-13-24(36)31(5,6)25(42-23)12-19(34)16(4)21-10-17-15(3)18(33)11-20(35)26(17)30(39)43-21/h11,16,19,21-25,27,29,33-37H,1,9-10,12-13H2,2-8H3,(H,32,38)/t16-,19+,21-,22+,23+,24-,25-,27+,29+/m1/s1

O1[C@H]([C@@H](NC([C@H]([C@H](CC(=C)C)OC)O)=O)OC)C[C@H](C(C)(C)[C@H]1C[C@@H]([C@@H](C)[C@H]1CC2C(C)=C(C=C(C=2C(=O)O1)O)O)O)O